FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Paul Hoskins

Research Profile

Procedures

Chemicals & Drugs

Disorders

Concepts & Ideas

Co-author Network

Publications

TOP 3
Alden A Moccia; Kerry J Savage; Tamara N Shenkier; Brian F Skinnider; Graham W Slack; Mukesh Chhanabhai; Joseph Michael Connors; Jane Donaldson; Randy D Gascoyne; Paul J Hoskins; Richard J Klasa; Laurie H Sehn
International Prognostic Score in advanced-stage Hodgkin's lymphoma: altered utility in the modern era.
Alicia A Tone; Dianne M Miller; Judith Pike; Shannon Salvador; Gavin C E Stuart; Kenneth D Swenerton; Anna V Tinker; Mark S Carey; Trevor Cohen; Tom Ehlen; Sarah J Finlayson; C Blake Gilks; Mark Heywood; Paul J Hoskins; David G Huntsman; Janice S Kwon; Cheng-Han Lee; Marette Lee; Jessica N McAlpine
The role of the fallopian tube in ovarian cancer.
Abdulwahab J Al-Tourah; Karamjit K Gill; Mukesh Chhanabhai; Paul J Hoskins; Richard J Klasa; Kerry J Savage; Laurie H Sehn; Tamara N Shenkier; Randy D Gascoyne; Joseph Michael Connors
Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Paul Hoskins (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Alden A Moccia; Kerry J Savage; Tamara N Shenkier; Brian F Skinnider; Graham W Slack; Mukesh Chhanabhai; Joseph Michael Connors; Jane Donaldson; Randy D Gascoyne; Paul J Hoskins; Richard J Klasa; Laurie H Sehn
International Prognostic Score in advanced-stage Hodgkin's lymphoma: altered utility in the modern era.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(27):3383-8.
2012: Alicia A Tone; Dianne M Miller; Judith Pike; Shannon Salvador; Gavin C E Stuart; Kenneth D Swenerton; Anna V Tinker; Mark S Carey; Trevor Cohen; Tom Ehlen; Sarah J Finlayson; C Blake Gilks; Mark Heywood; Paul J Hoskins; David G Huntsman; Janice S Kwon; Cheng-Han Lee; Marette Lee; Jessica N McAlpine
The role of the fallopian tube in ovarian cancer.
Clinical advances in hematology & oncology : H&O 2012;10(5):296-306.
2008: Abdulwahab J Al-Tourah; Karamjit K Gill; Mukesh Chhanabhai; Paul J Hoskins; Richard J Klasa; Kerry J Savage; Laurie H Sehn; Tamara N Shenkier; Randy D Gascoyne; Joseph Michael Connors
Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(32):5165-9.
2008: Paul J Hoskins; Nhu Le; Susan Ellard; Ursula Lee; Lee Ann Martin; kenneth d swenerton; Anna V Tinker
Carboplatin plus paclitaxel for advanced or recurrent uterine malignant mixed mullerian tumors. The British Columbia Cancer Agency experience.
Gynecologic oncology 2008;108(1):58-62.
2007: Laurie H Sehn; Brian Berry; Mukesh Chhanabhai; Catherine Fitzgerald; Karamjit Gill; Paul J Hoskins; Richard J Klasa; Kerry J Savage; Tamara N Shenkier; Judy Sutherland; Randy D Gascoyne; Joseph Michael Connors
The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP.
Blood 2007;109(5):1857-61.
2006: Abdulwahab J Al-Tourah; Peter W K Tsang; Brian F Skinnider; Paul J Hoskins
Paraneoplastic erythropoietin-induced polycythemia associated with small lymphocytic lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(15):2388-9.
2005: T G Ehlen; Paul J Hoskins; D Miller; Theresa L Whiteside; Christopher F Nicodemus; Birgit C Schultes; kenneth d swenerton
A pilot phase 2 study of oregovomab murine monoclonal antibody to CA125 as an immunotherapeutic agent for recurrent ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2005;15(6):1023-34.
2005: Joanna K Law; Jin K Ho; Paul J Hoskins; Siegfried R Erb; Urs P Steinbrecher; Eric M Yoshida
Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: potential implications for future prophylaxis recommendations.
Leukemia & lymphoma 2005;46(7):1085-9.
2005: A V Tinker; K Bhagat; kenneth d swenerton; Paul J Hoskins
Carboplatin and paclitaxel for advanced and recurrent cervical carcinoma: the British Columbia Cancer Agency experience.
Gynecologic oncology 2005;98(1):54-8.
2005: Tamara N Shenkier; Nicholas J Voss; Mukesh Chhanabhai; Randall Fairey; Randy D Gascoyne; Paul J Hoskins; Richard J Klasa; James Morris; Susan E O'Reilly; Tom Pickles; Laurie H Sehn; Joseph Michael Connors
The treatment of primary central nervous system lymphoma in 122 immunocompetent patients: a population-based study of successively treated cohorts from the British Colombia Cancer Agency.
Cancer 2005;103(5):1008-17.
2003: Paul J Hoskins; kenneth d swenerton; JA Pike; Peter Lim; Christina Aquino-Parsons; F Wong; N Lee
Small-cell carcinoma of the cervix: fourteen years of experience at a single institution using a combined-modality regimen of involved-field irradiation and platinum-based combination chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(18):3495-501.
2002: Tamara N Shenkier; Nicholas J Voss; Randall Fairey; Randy D Gascoyne; Paul J Hoskins; Richard J Klasa; Paul Klimo; Susan E O'Reilly; Simon Sutcliffe; Joseph Michael Connors
Brief chemotherapy and involved-region irradiation for limited-stage diffuse large-cell lymphoma: an 18-year experience from the British Columbia Cancer Agency.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(1):197-204.
2001: Paul J Hoskins; kenneth d swenerton; JA Pike; F Wong; Peter Lim; C Acquino-Parsons; N Lee
Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: a phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(20):4048-53.
1998: Paul J Hoskins; Dongsheng Tu; K James; Joseph L Pater; B Koski
Factors predictive of survival after first relapse or progression in advanced epithelial ovarian carcinoma: a prediction tree analysis-derived model with test and validation groups.
Gynecologic oncology 1998;70(2):224-30.
1998: Jean Latreille; Joseph L Pater; D Johnston; Francis Laberge; D Stewart; JJ Rusthoven; Paul J Hoskins; Brian Findlay; E McMurtrie; Louise Yelle; C Williams; D Walde; S Ernst; H Dhaliwal; David Warr; Frances A Shepherd; D Mee; L Nishimura; David Osoba; Benny Zee
Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapy. National Cancer Institute of Canada Clinical Trials Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(3):1174-8.
1997: Paul J Hoskins; Nhu Le; Randy D Gascoyne; Richard J Klasa; Tamara N Shenkier; Susan O'Reilly; Joseph Michael Connors
Advanced diffuse large-cell lymphoma treated with 12-week combination chemotherapy: natural history of relapse after initial complete response and prognostic variables defining outcome after relapse.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(11):1125-32.
1997: WS Lofters; Joseph L Pater; Benny Zee; E Dempsey; D Walde; J P Moquin; K Wilson; Paul J Hoskins; R M Guevin; S Verma; R Navari; J E Krook; J Hainsworth; Michael Palmer; C Chin
Phase III double-blind comparison of dolasetron mesylate and ondansetron and an evaluation of the additive role of dexamethasone in the prevention of acute and delayed nausea and vomiting due to moderately emetogenic chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(8):2966-73.
1997: Randy D Gascoyne; SA Adomat; Stan Krajewski; Maryla Krajewska; Douglas E Horsman; Anthony W Tolcher; Susan E O'Reilly; Paul J Hoskins; Andrew J Coldman; JC Reed; Joseph Michael Connors
Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma.
Blood 1997;90(1):244-51.
1997: Susan E O'Reilly; Joseph Michael Connors; Nicol Macpherson; Richard J Klasa; Paul J Hoskins
Malignant lymphomas in the elderly.
Clinics in geriatric medicine 1997;13(2):251-63.
1997: E Al-Saleh; Paul J Hoskins; JA Pike; kenneth d swenerton
Cisplatin/etoposide chemotherapy for recurrent or primarily advanced cervical carcinoma.
Gynecologic oncology 1997;64(3):468-72.
1997: Joseph L Pater; WS Lofters; Benny Zee; E Dempsey; D Walde; J P Moquin; K Wilson; Paul J Hoskins; R M Guevin; S Verma; R Navari; J E Krook; J Hainsworth; Michael Palmer; C Chin
The role of the 5-HT3 antagonists ondansetron and dolasetron in the control of delayed onset nausea and vomiting in patients receiving moderately emetogenic chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(2):181-5.
1996: K Swenerton; Paul J Hoskins; G Stuart; G Batist; J Pike; N Onetto; B Fisher; Elizabeth Eisenhauer
A phase I study of bi-weekly paclitaxel/cisplatin as initial therapy for advanced ovarian cancer. A study of the National Cancer Institute of Canada Clinical Trials Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(10):1077-9.
1996: Paul J Hoskins; kenneth d swenerton; J A Pike; E M McMurtrie; N Lee
"MECCA": a developmental, dose-intensive, non-cross-resistant platinum-based chemotherapy for advanced ovarian cancer.
Gynecologic oncology 1996;63(3):345-51.
1996: H L Woo; kenneth d swenerton; Paul J Hoskins
Taxol is active in platinum-resistant endometrial adenocarcinoma.
American journal of clinical oncology 1996;19(3):290-1.
1995: Jean Latreille; D Stewart; Francis Laberge; Paul J Hoskins; JJ Rusthoven; E McMurtrie; David Warr; Louise Yelle; D Walde; Frances A Shepherd
Dexamethasone improves the efficacy of granisetron in the first 24 h following high-dose cisplatin chemotherapy.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1995;3(5):307-12.
1995: Paul J Hoskins; F Wong; kenneth d swenerton; J A Pike; M Manji; E McMurtrie; B Acker; J Le Riche
Small cell carcinoma of the cervix treated with concurrent radiotherapy, cisplatin, and etoposide.
Gynecologic oncology 1995;56(2):218-25.
1994: L Kaizer; David Warr; Paul J Hoskins; Jean Latreille; WS Lofters; J Yau; Michael Palmer; Benny Zee; M Levy; Joseph L Pater
Effect of schedule and maintenance on the antiemetic efficacy of ondansetron combined with dexamethasone in acute and delayed nausea and emesis in patients receiving moderately emetogenic chemotherapy: a phase III trial by the National Cancer Institute of Canada Clinical Trials Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(5):1050-7.
1994: Paul J Hoskins; kenneth d swenerton
Oral etoposide is active against platinum-resistant epithelial ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(1):60-3.
1993: Susan E O'Reilly; Joseph Michael Connors; S Howdle; Paul J Hoskins; Richard J Klasa; Paul Klimo; D S Stuart
In search of an optimal regimen for elderly patients with advanced-stage diffuse large-cell lymphoma: results of a phase II study of P/DOCE chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(11):2250-7.
1992: Paul J Hoskins; Susan E O'Reilly; kenneth d swenerton; John Spinelli; Randall Fairey; J L Benedet
Ten-year outcome of patients with advanced epithelial ovarian carcinoma treated with cisplatin-based multimodality therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(10):1561-8.
1991: Paul J Hoskins; V Ng; John Spinelli; P Klimo; Joseph Michael Connors
Prognostic variables in patients with diffuse large-cell lymphoma treated with MACOP-B.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(2):220-6.
1991: Susan E O'Reilly; Paul J Hoskins; Paul Klimo; Joseph Michael Connors
MACOP-B and VACOP-B in diffuse large cell lymphomas and MOPP/ABV in Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2 Suppl 1():17-23.
1990: Paul J Hoskins; E McMurtrie; kenneth d swenerton
A phase II trial of mitomycin in patients with epithelial ovarian carcinoma resistant to cisplatin or carboplatin.
American journal of clinical oncology 1990;13(5):416-9.
1990: Paul J Hoskins; Chris Coppin; Nevin Murray
Mitomycin is active against refractory germ-cell tumors. A phase II study.
American journal of clinical oncology 1990;13(1):35-8.